全文获取类型
收费全文 | 4816篇 |
免费 | 395篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 156篇 |
妇产科学 | 174篇 |
基础医学 | 739篇 |
口腔科学 | 54篇 |
临床医学 | 578篇 |
内科学 | 841篇 |
皮肤病学 | 111篇 |
神经病学 | 441篇 |
特种医学 | 99篇 |
外科学 | 311篇 |
综合类 | 61篇 |
一般理论 | 6篇 |
预防医学 | 629篇 |
眼科学 | 69篇 |
药学 | 526篇 |
中国医学 | 2篇 |
肿瘤学 | 408篇 |
出版年
2023年 | 39篇 |
2022年 | 62篇 |
2021年 | 101篇 |
2020年 | 74篇 |
2019年 | 129篇 |
2018年 | 124篇 |
2017年 | 96篇 |
2016年 | 146篇 |
2015年 | 121篇 |
2014年 | 205篇 |
2013年 | 266篇 |
2012年 | 384篇 |
2011年 | 353篇 |
2010年 | 187篇 |
2009年 | 187篇 |
2008年 | 288篇 |
2007年 | 353篇 |
2006年 | 306篇 |
2005年 | 311篇 |
2004年 | 289篇 |
2003年 | 228篇 |
2002年 | 275篇 |
2001年 | 45篇 |
2000年 | 35篇 |
1999年 | 45篇 |
1998年 | 59篇 |
1997年 | 42篇 |
1996年 | 45篇 |
1995年 | 34篇 |
1994年 | 35篇 |
1993年 | 34篇 |
1992年 | 16篇 |
1991年 | 25篇 |
1990年 | 11篇 |
1989年 | 19篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 15篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1974年 | 10篇 |
1973年 | 11篇 |
1972年 | 8篇 |
1971年 | 8篇 |
排序方式: 共有5217条查询结果,搜索用时 0 毫秒
71.
PURPOSE: Among patients with deep vein thrombosis, hypercoagulable conditions impart a substantial risk of recurrent thrombosis. We sought to determine the cost-effectiveness of testing for these disorders, as well as which tests should be selected and how results should be used. METHODS: Using a Markov state-transition model, strategies of testing or not testing for a hypercoagulable state followed by anticoagulation for 6 to 36 months were compared in a hypothetical cohort of patients with apparently idiopathic deep vein thrombosis who were followed for life. Strategies were compared based on lifetime costs, quality-adjusted life-years (QALYs), and marginal cost-effectiveness. RESULTS: In the base case, testing followed by 24 months of anticoagulation in patients with a hypercoagulable condition was more cost-effective ($54,820; 23.76 QALYs) than usual care, which comprised 6 months of anticoagulation without testing ($55,260; 23.72 QALYs). All hypercoagulable conditions tested were common enough and associated with a sufficient risk of recurrence to justify inclusion in a test panel. Twenty-four months of initial anticoagulation was preferred (<$50,000/QALY) for most conditions, whereas lifetime anticoagulation was preferred for patients with antiphospholipid antibody syndrome ($2928/QALY) or homozygous factor V Leiden mutation ($3804/QALY). Models using newer evidence on recurrence suggested 18 to 36 months of anticoagulation without testing as the preferred approach. CONCLUSION: Testing for hypercoagulable disorders in patients with idiopathic deep vein thrombosis followed by 2 years of anticoagulation in affected patients is cost-effective. A simpler approach of treating all patients with prolonged anticoagulation without testing is justified if data confirm the persistent risk of recurrent thrombosis. 相似文献
72.
Barriers and facilitators to recruitment in mental health services: Care coordinators' expectations and experience of referring to a psychosis research trial 下载免费PDF全文
73.
74.
75.
76.
Nitin Kapur Gillian Nixon Philip Robinson John Massie Bernadette Prentice Andrew Wilson Sandra Schilling Jacob Twiss Dominic A. Fitzgerald 《Respirology (Carlton, Vic.)》2020,25(8):880-888
Chronic neonatal lung disease (CNLD) is defined as continued need for any form of respiratory support (supplemental oxygen and/or assisted ventilation) beyond 36 weeks PMA. Low‐flow supplemental oxygen facilitates discharge from hospital of infants with CNLD who are hypoxic in air and is widely used despite lack of evidence on the most appropriate minimum mean target oxygen saturations. Furthermore, there are minimal data to guide the home monitoring, titration or weaning of supplemental oxygen in these infants. The purpose of this position statement is to provide a guide for the respiratory management of infants with CNLD, with special emphasis on role and logistics of supplemental oxygen therapy beyond the NICU stay. Reflecting a variety of clinical practices and infant comorbidities (presence of pulmonary hypertension, retinopathy of prematurity and adequacy of growth), it is recommended that the minimum mean target range for SpO2 during overnight oximetry to be 93–95% with less than 5% of total recording time to be below 90% SpO2. Safety of short‐term disconnection from supplemental oxygen should be assessed before discharge, with majority of infants with CNLD not ready for discharge until supplemental oxygen requirement is ≤0.5 L/min. Sleep‐time assessment of oxygenation with continuous overnight oximetry is recommended when weaning supplemental oxygen. Palivizumab is considered safe and effective for the reduction of hospital admissions with RSV infection in this group. This statement would be useful for paediatricians, neonatologists, respiratory and sleep physicians and general practitioners managing children with CNLD. 相似文献
77.
78.
Purpose
The aim of this study was to assess the impact of changes in respiratory support (RS) settings recommended after a titration polysomnography (PSG), in terms of daytime symptoms and quality of life.Methods
A retrospective chart review of all RS (CPAP and bi-level ventilation) titration studies was carried out at our tertiary paediatric sleep laboratory in the past 5 years. All patients with at least two studies in the past 5 years were included in the analysis. Parents completed the obstructive sleep apnoea (OSA)-18 and Paediatric Daytime Sleepiness Scale (PDSS) questionnaires on the night of each PSG. Results are presented as means (SD).Results
A total of 42 patients (25 on CPAP and 17 on bi-level ventilation, age 11 (6)?years) had 71 pairs of titration studies (41 CPAP and 30 bi-level). Changes in RS settings were recommended in 27 of 41 (65 %) CPAP studies and 11 of 30 (36 %) bi-level studies. Overall, changes were fully implemented by the treating physician in 55 % of cases. There was an improvement in total OSA-18 score between studies in 48 % of the paired CPAP studies and 65 % of bi-level studies. OSA-18 scores improved in 47 % of the studies where any recommended change had been implemented versus 0 % of those where none of the recommended changes had been made (p?=?0.1).Conclusions
Titration studies frequently led to recommendations for a change in RS settings in these patients on long-term RS. Symptom scores were more likely to improve if recommendations for change were implemented by the time of the follow-up study. 相似文献79.
80.
Katrien Wijndaele Gillian Orrow Ulf Ekelund Stephen J. Sharp Søren Brage Simon J. Griffin Rebecca K. Simmons 《Diabetologia》2014,57(2):305-312